AminoMultiPlex delivers a curated selection of amino acids chosen for their roles in muscle repair, natural recovery, nutrient utilization and metabolic support
The provider may recommend KLOW, a single peptide, another treatment approach or no peptide therapy based on your health history and goals
Triple-hormone-receptor agonist Retatrutide for obesity: Phase 2 trial (48-week study, up to 24% weight loss) American Diabetes Association (2023) ADA Press Release: Novel agent Retatrutide results in substantial weight reduction (83rd Scientific Sessions, Phase 2 data) ADA Meeting News (2023) Phase 2 trial results: benefits of Retatrutide in obesity, type 2 diabetes, NASH (83rd ADA Scientific Sessions coverage) ClinicalTrials.gov Study of Retatrutide (LY3437943) in adults with obesity (NCT04881760
After the Meeting Rulemaking
Final Call to Action For high-volume requirements or technical specifications, please contact our expert team at Farbe Firma today